TL; DR
Rem3dy Health has raised £14m from Suntory, Apollo Hospitals, Estrella Galicia and UPSA at a £84m valuation to expand its Nourishing vitamin brand globally.
Birmingham-based Rem3dy Health, parent company of personal vitamin brand Nourished, It raised £14m at a cost of £84m in a round backed by a mix of global strategic investors. The tour was led by Japanese beverage and health group Suntory, Spanish brewing conglomerate Estrella Galicia, Indian healthcare provider Apollo Hospitals and French pharmaceutical company UPSA. Future Planet Capital Regional, which manages the West Midlands Co-Investment Fund, also participated.
The company plans to use the funds to enter the US, the MENA region and India, while expanding its personalized pet health solutions. Rem3dy Health now sells Nourished products in Boots, Holland & Barrett and over 12,000 pharmacies across Europe and has built its manufacturing base on 3D printing technology, which has seen patent filings grow eight times faster than the average for all other sectors.. The company said it has sold more than 53 million units since its launch in 2020.
Founded in 2019 by registered dietitian and serial entrepreneur Melissa Snover, Rem3dy Health uses patented 3D printing to produce seven-layer vegan gummy stacks customized for individual health goals. Customers fill out a questionnaire and an algorithm recommends pairings with what the company says are more than 10 million possible food configurations. According to Snover, these gums are printed on demand at the company’s facility, which can produce 500,000 units per day.
“Securing this funding is a huge milestone for us,“Snover said.”After a significant year of transformation and facing one of the most challenging fundraising environments in recent years, we are now in a strong position to expand globally.” VoxelMatters reports that the company has previously raised around £19 million in previous rounds, making it the largest single fundraise to date.
Investor mix points to cross-sector interest personalized nutrition, a category that is attracting increasing attention from both strategic investors and athletes. Apollo Hospitals operates more than 70 hospitals and 6,000 pharmacies in India, giving Rem3dy Health a potential distribution partner in one of its target markets. Estrella Galicia’s involvement shows the Spanish company is looking beyond its core brewing and food businesses into health-related categories.
Rupert Lyle, Future Planet Capital Regional Investment Director and Fund Director of West Midlands Mutual Investment Fund, said the round reflected the company’s trajectory. “When we first invested in Rem3dy, it was clear that they were developing a truly disruptive brand and technology that could revolutionize the global health industry.” said Lyle.Future Planet Capital Regional previously invested £500,000 in Rem3dy Health in September 2025 through a £25m vehicle backed equally by West Midlands Combined Investment Fund and West Midlands Combined Authority and West Midlands Pension Fund.
Round fits a wider model investor interest in companies that combine data, personalization and technology to deliver healthcare at scale. Whether Rem3dy Health’s 3D-printed gums represent a genuine breakthrough in nutritional science or a well-packaged consumer health product is a question the company will have to answer as it moves into markets where regulatory scrutiny of health claims is more stringent than the UK.
